Prevalence and determinants of lymphedema in newly diagnosed Nigerian breast cancer patients using bioimpedance estimations

9 Feb 2023
Funmilola Wuraola, Olalekan Olasehinde, Matteo Di Bernardo, Patrick Akinyemi, Israel Owoade, Tajudeen Mohammed, Adewale Aderounmu, Samson Ogunleye, Adeoluwa Adeleye, Mary Ogunyemi, Gregory Knapp, Peter Kingham, Olusegun Alatise

Background: Breast cancer-related lymphedema (BCRL) is common and has significant impact on quality of life. Very little is known about BCRL in sub-Saharan Africa. Generally, BCRL has been mostly evaluated post treatment, with very limited data on the prevalence of pre-treatment BCRL at baseline. This study presents the prevalence and clinical associations of lymphedema among newly diagnosed, treatment-naive breast cancer patients in a Nigerian cohort using bioimpedance estimations.

Methods: Consecutively consenting, newly diagnosed, treatment-naive breast cancer patients were assessed for upper limb lymphedema using bioimpedance measurements of the extracellular fluid and the single-frequency bioelectrical impedance analysis value at 5 kHz. Patients were classified as having lymphedema if there was >10% difference in arm measurements or if the ratios of the arm measurements were >3 SD above a normative mean generated from representative controls. Regression analysis was performed to determine clinical variables associated with lymphedema.

Results: There were 154 breast cancer patients with a median age of 47 (40.0–56.8) years and a body mass index of 27 (23.5–30.9) kg/m2. The majority (70%) had stage III disease. All measurements were significantly higher in cases than controls. Using various definitions, the prevalence of lymphedema was between 11.7% and 14.3%. Various clinical variables relating to clinical stage were significantly associated with lymphedema.

Conclusion: The predominance of locally advanced disease in the Nigerian setting is associated with high pre-treatment lymphedema rates. This may set the stage for higher rates in the post-operative setting. Management of lymphedema should be incorporated into the treatment planning.

Related Articles

Mariana Carvalho Gouveia, Cassio Murilo Hidalgo Filho, Raquel Andrade Moreno, Heitor Castelo Branco Rodrigues Alves, Aline Sgnolf Ayres, Laura Testa, Renata Colombo Bonadio
Ralph Victor Yap, Deanne Lou Marquez, Frances Marion De La Serna
Evelyn Lilian Beas-Lozano, Haydeé Cristina Verduzco-Aguirre, Roberto Gonzalez-Salazar, Yanin Chavarri-Guerra
Fernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, Gonzalo Gomez Abuin, José Peñaloza, Marcos Ariel Flores, Luciano Piazzoni, Cecilia Riggi, Lucía Fabiano, Lucía González, Belén Cieplinski, Sergio Rivero, Ernesto Korbenfeld, Pablo Mandó
Katsuki Arima Tiscoski, Juliana Giacomazzi, Matheus Soares Rocha, Gustavo Gössling, Gustavo Werutsky
Benjamín Walbaum, José Miguel Reyes, Pablo Rodriguez, Sabrina Muñiz, Lidia Medina, Carolina Ibáñez, Tomás Merino, Mauricio P Pinto, Maria Loreto Bravo, Francisco Acevedo, José Bennett, Cesar Sánchez